SIO

November 12, 2020

Integrative Medicine’s Most Intentional Intersection: SIO and ASCO to Produce 3 New Oncology Guidelines

The early “integrative medicine” period clearly was one of “non-integrated integration.” The hospital or insurer wanted to throw the consumer an integrative bone in the competitive marketplace. They produced stand-alone integrative clinics or a carve-out insurance products. Offerings, in these forms, serve dual purposes. The medical delivery organization or insurer pleases patients by offering a little yoga, or acupuncture, or manipulative therapy or massage. At the same time, the non-integrated nature of what is offered pleases medical leadership: they are not asked to take the integrative methods seriously. They needn’t cross the medical-cultural divide to weigh whether the integrative approaches may be better than usual care. For most of the past decade, the Society for Integrative Oncology (SIO) has been building bridges across the chasm. Twice they’ve developed integrative oncology guidelines with mainstream oncology organizations. Now, through an unrestricted grant from the Samueli Foundation, SIO and the influential American Society for Clinical Oncology (ASCO) are commencing a project to raise three additional girders to bridge treatments.